BR112012027093A2 - prevenção e tratamento de infecção gastrointestinal em mamíferos - Google Patents
prevenção e tratamento de infecção gastrointestinal em mamíferosInfo
- Publication number
- BR112012027093A2 BR112012027093A2 BR112012027093A BR112012027093A BR112012027093A2 BR 112012027093 A2 BR112012027093 A2 BR 112012027093A2 BR 112012027093 A BR112012027093 A BR 112012027093A BR 112012027093 A BR112012027093 A BR 112012027093A BR 112012027093 A2 BR112012027093 A2 BR 112012027093A2
- Authority
- BR
- Brazil
- Prior art keywords
- prevention
- treatment
- diseases
- mammals
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
prevenção e tratamento de infecção gastrointestinal em mamíferos. os métodos são descritos para prevenção e/ou tratamento de certas doenças gastrointestinais (gi), tais como as doenças de johne (jd) em animais e doença de crohn (cd) em seres humanos. a administração de certas bactérias probióticas, tais como bactérias produtoras de ácido lático, a animais auxilia a inibir a infecção do gi por mycobacterium avium subsp. paratuberculosis (map). map é o agente patogênico primário suspeito de causar várias doenças intestinais inflamatórias em gado ou seres humanos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32736810P | 2010-04-23 | 2010-04-23 | |
PCT/US2011/033612 WO2011133887A2 (en) | 2010-04-23 | 2011-04-22 | Prevention and treatment of gastrointestinal infection in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012027093A2 true BR112012027093A2 (pt) | 2016-07-26 |
Family
ID=44834832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012027093A BR112012027093A2 (pt) | 2010-04-23 | 2011-04-22 | prevenção e tratamento de infecção gastrointestinal em mamíferos |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130189236A1 (pt) |
CN (1) | CN103327989B (pt) |
AU (1) | AU2011242574B2 (pt) |
BR (1) | BR112012027093A2 (pt) |
CA (1) | CA2797185A1 (pt) |
MX (1) | MX338684B (pt) |
NZ (1) | NZ603461A (pt) |
WO (1) | WO2011133887A2 (pt) |
ZA (1) | ZA201207957B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
CN106535941A (zh) * | 2014-05-22 | 2017-03-22 | 约翰·托德·金斯特纳 | 使用紫外线血液辐照和抗生素的组合治疗疾病 |
EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
CA3015688A1 (en) * | 2016-02-25 | 2017-08-31 | Thomas Julius Borody | Compositions and methods of treatment of chronic infectious diseases |
KR101680014B1 (ko) | 2016-07-04 | 2016-11-29 | 한국식품연구원 | 김치로부터 분리한 염증성 장 질환 치료 효과를 갖는 유산균 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020192201A1 (en) * | 1998-09-24 | 2002-12-19 | Ira Shafran | Crohn's disease treatment methods |
US6297015B1 (en) * | 1998-09-24 | 2001-10-02 | Ira Shafran | Crohn's disease diagnostic and treatment methods and compositions |
AU2007285285B2 (en) * | 2006-08-15 | 2010-08-12 | Meiji Seika Pharma Co., Ltd. | Antibacterial agent and therapeutic agent for Johne's disease comprising the same |
RU2466185C2 (ru) * | 2007-03-28 | 2012-11-10 | Элиментари Хелт Лимитед | ПРОБИОТИЧЕСКИЙ ШТАММ Bifidobacterium longum, ПРОБИОТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЯ ШТАММА Bifidobacterium longum |
AU2009341473B2 (en) * | 2009-03-05 | 2016-04-21 | Probiotical S.P.A. | Bacteria strains having a high anti-inflammatory activity |
CN102711819A (zh) * | 2009-09-23 | 2012-10-03 | 托马斯·朱利叶斯·波洛迪 | 肠道感染疗法 |
-
2011
- 2011-04-22 MX MX2012012372A patent/MX338684B/es active IP Right Grant
- 2011-04-22 AU AU2011242574A patent/AU2011242574B2/en not_active Ceased
- 2011-04-22 WO PCT/US2011/033612 patent/WO2011133887A2/en active Application Filing
- 2011-04-22 CN CN201180027672.6A patent/CN103327989B/zh not_active Expired - Fee Related
- 2011-04-22 BR BR112012027093A patent/BR112012027093A2/pt not_active Application Discontinuation
- 2011-04-22 CA CA2797185A patent/CA2797185A1/en not_active Abandoned
- 2011-04-22 US US13/643,023 patent/US20130189236A1/en not_active Abandoned
- 2011-04-22 NZ NZ603461A patent/NZ603461A/en not_active IP Right Cessation
-
2012
- 2012-10-23 ZA ZA2012/07957A patent/ZA201207957B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN103327989A (zh) | 2013-09-25 |
ZA201207957B (en) | 2013-07-31 |
MX338684B (es) | 2016-04-26 |
AU2011242574B2 (en) | 2016-09-29 |
MX2012012372A (es) | 2012-11-30 |
US20130189236A1 (en) | 2013-07-25 |
WO2011133887A9 (en) | 2012-03-08 |
AU2011242574A1 (en) | 2012-11-15 |
NZ603461A (en) | 2015-02-27 |
WO2011133887A2 (en) | 2011-10-27 |
CA2797185A1 (en) | 2011-10-27 |
CN103327989B (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012027093A2 (pt) | prevenção e tratamento de infecção gastrointestinal em mamíferos | |
Hoffmann | The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals | |
BR112013027609A2 (pt) | bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos | |
BR112013031325A2 (pt) | cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori | |
Percival et al. | Biofilms and Helicobacter pylori: dissemination and persistence within the environment and host | |
BR112012030359A2 (pt) | cepas probióticas para uso no aperfeiçoamento do sistema nervoso entérico | |
BR112015028338A2 (pt) | métodos de diagnóstico ou de auxílio no diagnóstico e de tratamento da doença inflamatória intestinal | |
BR112013001577A2 (pt) | conjugados de carboidrato e dihidorxiclorina e clorina <225>-funcionalizada e respectivos usos e método para eliminar microorganismos em ambiente de paciente real | |
BR112017008184A2 (pt) | composições e linhagem | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
Garcia et al. | Report of the first Vagococcus lutrae human infection, Marseille, France | |
JP2013147469A5 (pt) | ||
Hu et al. | Modulation of cytokine gene expression by selected Lactobacillus isolates in the ileum, caecal tonsils and spleen of Salmonella-challenged broilers | |
BR112015017903A2 (pt) | vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios | |
FARAHMAND et al. | Identification of Toxic Shock Syndrome Toxin-1 (TSST-1) gene in Staphylococcus aureus isolated from bovine mastitis milk | |
RS57471B1 (sr) | Nova probiotička starter kultura za humanu i animalnu primenu | |
MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
JP2014101282A5 (pt) | ||
EA201600347A2 (ru) | Гибридный белок, днк, генетическая конструкция, продуцент, вакцина на основе гибридного белка для профилактики и лечения туберкулеза (варианты) | |
JP2014101288A5 (pt) | ||
Budiarti | Antibiotic resistance Escherichia coli isolated from faecal of healthy human | |
Ngeow et al. | Genome sequence of Mycobacterium abscessus strain M152 | |
Onyango et al. | Severe orf in lambs: Clinical description and response to treatment against secondary infection | |
Malmarugan et al. | Diagnosis and therapeutic management of goat pox in ovines. | |
Barman et al. | IDENTIFICATION OF INFECTIOUS ORGANISMS FROM ANIMAL WOUNDS AND CHARACTERIZATION OF TOXIN BY IN VITRO AN DIN VIVO METHODS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: CHR. HANSEN A/S (DK) |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |